Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials
Authors
Keywords
-
Journal
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-03-31
DOI
10.1002/ccd.27615
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke
- (2018) Rahman Shah et al. ANNALS OF INTERNAL MEDICINE
- Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke
- (2017) Mohammad Khalid Mojadidi et al. JACC-Cardiovascular Interventions
- Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke
- (2017) Minsu Kim et al. JOURNAL OF INTERVENTIONAL CARDIOLOGY
- Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
- (2017) Lars Søndergaard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
- (2017) Jeffrey L. Saver et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
- (2017) Jean-Louis Mas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Device Closure of Patent Foramen Ovale After Stroke
- (2016) David M. Kent et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter)
- (2016) Steven R. Messé et al. NEUROLOGY
- The Role of Patent Foramen Ovale in Cryptogenic Stroke
- (2016) Songul Senadim et al. Noropsikiyatri Arsivi-Archives of Neuropsychiatry
- Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases
- (2015) Mikaeil Mirzaali et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Cost Effectiveness of Percutaneous Closure Versus Medical Therapy for Cryptogenic Stroke in Patients With a Patent Foramen Ovale
- (2014) Christopher A. Pickett et al. AMERICAN JOURNAL OF CARDIOLOGY
- Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
- (2014) Walter N. Kernan et al. STROKE
- Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale
- (2014) Frederick A Spencer et al. BMJ Open
- Is Transcatheter Closure Better than Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale? A Meta-analysis of Randomised Trials
- (2013) Vinayak Nagaraja et al. Heart Lung and Circulation
- Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
- (2013) John D. Carroll et al. NEW ENGLAND JOURNAL OF MEDICINE
- Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
- (2013) Bernhard Meier et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Risk of Paradoxical Embolism (RoPE) Study: Initial Description of the Completed Database
- (2012) David E. Thaler et al. International Journal of Stroke
- Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
- (2012) Anthony J. Furlan et al. NEW ENGLAND JOURNAL OF MEDICINE
- What is “quality of evidence” and why is it important to clinicians?
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started